Hikma Pharmaceuticals (HIK)

 

Latest News

Holding(s) in Company

RNS Number: 2220X Hikma Pharmaceuticals Plc 22 November 2017 TR-1: S tandard form for notification of major holdings LONDON, 22 November 2017 - Hikma Pharmaceuticals PLC ("Hikma") (LSE: HIK) (DIFX: HIK) (LEI: 549300BNS685UXH4JI75) , the fast-growing multinational pharmaceuticals group, announces as follows: NOTIFICATION OF MAJOR HO...

Holding(s) in Company

RNS Number: 9563W Hikma Pharmaceuticals Plc 20 November 2017 TR-1: S tandard form for notification of major holdings LONDON, 20 November 2017 - Hikma Pharmaceuticals PLC ("Hikma") (LSE: HIK) (DIFX: HIK) (LEI: 549300BNS685UXH4JI75) , the fast-growing multinational pharmaceuticals group, announces as follows: NOTIFICATION OF MAJOR HO...

Broker Forecast - Peel Hunt issues a broker note on Hikma Pharmaceuticals PLC

Peel Hunt today reaffirms its hold investment rating on Hikma Pharmaceuticals PLC (LON:HIK) and set its price target at...

Holding(s) in Company

RNS Number: 4246W Hikma Pharmaceuticals Plc 14 November 2017 TR-1: S tandard form for notification of major holdings LONDON, 14 November 2017 - Hikma Pharmaceuticals PLC ("Hikma") (LSE: HIK) (DIFX: HIK) (LEI: 549300BNS685UXH4JI75) , the fast-growing multinational pharmaceuticals group, announces as per the attached: NOTIFICATION OF MA...

All News

DateHeadlineSource
22-11-17Holding(s) in CompanyRNS
20-11-17Holding(s) in CompanyRNS
14-11-17Broker Forecast - Peel Hunt issues a broker note on Hikma Pharmaceuticals PLCStockMarketWire
14-11-17Holding(s) in CompanyRNS
14-11-17Hikma Acquires Products from Boehringer IngelheimRNS
10-11-17Broker Forecast - JP Morgan Cazenove issues a broker note on Hikma Pharmaceuticals PLCStockMarketWire
10-11-17Broker Forecast - HSBC issues a broker note on Hikma Pharmaceuticals PLCStockMarketWire
09-11-17Time to buy bombed-out Hikma Pharmaceuticals?Interactive Investor
09-11-17Broker Forecast - Numis issues a broker note on Hikma Pharmaceuticals PLCStockMarketWire
09-11-17Broker Forecast - Stifel issues a broker note on Hikma Pharmaceuticals PLCStockMarketWire
09-11-17UK housing market setback weighs on FTSE StockMarketWire
09-11-17Hikma maintains revenues forecastsStockMarketWire
09-11-17Trading StatementRNS
08-11-17Holding(s) in CompanyRNS
03-11-17Hikma US unit launches generic equivalents to AncobonStockMarketWire
03-11-17Hikma launches Flucytosine Capsules USP in USRNS
02-11-17Holding(s) in CompanyRNS
01-11-17Total Voting RightsRNS
30-10-17Hikma US unit launches Pantoprazole sodium for injectionStockMarketWire
30-10-17Hikma launches Pantoprazole Sodium for InjectionRNS
06-10-17Broker Forecast - JP Morgan Cazenove issues a broker note on Hikma Pharmaceuticals PLCStockMarketWire
05-10-17Block listing Interim ReviewRNS
02-10-17Total Voting RightsRNS
28-09-17Holding(s) in CompanyRNS
25-09-17Holding(s) in CompanyRNS
14-09-17Holding(s) in CompanyRNS
01-09-17Broker Forecast - Cantor Fitzgerald issues a broker note on Hikma Pharmaceuticals PLCStockMarketWire
29-08-17Broker Forecast - Stifel issues a broker note on Hikma Pharmaceuticals PLCStockMarketWire
25-08-17Holding(s) in CompanyRNS
25-08-17Broker Forecast - Barclays Capital issues a broker note on Hikma Pharmaceuticals PLCStockMarketWire
24-08-17Broker Forecast - Citigroup issues a broker note on Hikma Pharmaceuticals PLCStockMarketWire
22-08-17Broker Forecast - Goldman Sachs issues a broker note on Hikma Pharmaceuticals PLCStockMarketWire
22-08-17Stockwatch: Is this a coiled spring or a falling knife?Interactive Investor
21-08-17Peel Hunt cuts earnings by 30% for HikmaStockMarketWire
21-08-17Broker Forecast - Morgan Stanley issues a broker note on Hikma Pharmaceuticals PLCStockMarketWire
21-08-17Broker Forecast - Jefferies International issues a broker note on Hikma Pharmaceuticals PLCStockMarketWire
21-08-17Broker Forecast - Peel Hunt issues a broker note on Hikma Pharmaceuticals PLCStockMarketWire
17-08-17FTSE remains weak on underwhelming financial stocks StockMarketWire
17-08-17Down 50% since March but still a 'buy'Interactive Investor
17-08-17Slump in banking stocks hit FTSE StockMarketWire

RSS feeds

  • Editorial news feed for LSE:HIK Editorial
  • Regulatory news feed for LSE:HIK Regulatory

Join interactive investor

  • £22.50 fixed quarterly charge includes £22.50 in trading credits
  • £10 per trade or £6 for frequent traders
  • No % platform fees
  • £1 per trade for regular investment or dividend reinvestment

Open an account